Hepatocellular carcinoma (HCC or hepatoma) is the most common primary liver malignancy. Chronic hepatic inflammation is the major driving factor in the development of HCC. Risk factors vary by regional exposures. As chronic Hepatitis B virus (HBV) infection is the most common risk factor leading ...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Imaging is important for establishing a diagnosis of HCC. Several imaging modalitie... Tiffany,Hennedige,S Kundapur,... - 《Cancer Imaging the Official Publication of the International Cancer Imaging Society》 被引量: 125发表...
Liver Transplantation for Hepatocellular Carcinoma Liver transplantation has emerged as an optimal treatment for stage I and II hepatocellular carcinoma for patients with underlying cirrhosis as it provides... JK Heimbach - 《Cancer Journal》 被引量: 5发表: 2008年 加载更多来源...
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation Snaebjornsson et al. explore a selective vulnerability in cancer elicited by targeting aldolase A, which causes energy imbalance and prevents further metabolic adaptations. ...
Chapter 9 Liver Cancer Hepatocellular and Fibrolamellar Hepatocellular Carcinoma Janio Szklaruk, M.D., Ph.D.; , Eddie K. Abdalla, M.D. , Ahmed O. Kaseb, M.D. , Sunil Krishnan, M.D. I Hepatocellular Carcinoma Introduction Hepatocellular carcinoma (HCC) is one of the most common malignant...
全部来源 求助全文 Elsevier onAcademic ejcancer.com 相似文献 参考文献 引证文献Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease AIM: To determine characteristics and prognosticpredictors of patients with hepatocellular carcinoma(HCC) in association ...
Objective: To study the clinical value of centromere protein L (CENPL) in the recurrence of hepatocellular carcinoma after liver transplantation. Methods: A total of 93 patients with liver cancer recurrence after liver transplantation were selected (REC group), and 46 non-recurrence patients who unde...
Title Deleted in liver cancer 1 ( DLC 1 ) negatively regulatesRho / ROCK / MLC pathway in hepatocellular carcinoma Aims: Deleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity an... CC Wong,Y ...
Evaluation of hepatocellular carcinoma with dysplastic nodule in liver cirrhosis with spiral CT and MRI as well as interventional therapeuticsDONG Jin-wen,YAN Zhi-gang,LIAO Shun-ming,LU Rong. Evaluation of hepatocellular carcinoma with dysplastic nodule...
The urgent unmet need for hepatocellular carcinoma (HCC) therapies is addressed here by characterising a novel mouse model of HCC in the context of ongoing liver damage and overnutrition. Male C57Bl/6J mice were treated with diethylnitrosamine (DEN) and